Nasal Immunotherapy to Parietaria: Evidence of Reduction of Local Allergic Inflammation
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Studies over 10 yr have demonstrated local nasal immunotherapy (LNIT) to be an effective treatment for rhinitis due to pollens and mites. The aim of our work was to investigate the effects of LNIT on the local inflammatory phenomena, employing the model of nasal allergenic challenge, since no evidence has been yet provided about LNIT effects on the events due to allergic reactions. We evaluated, in addition, the possible effects of LNIT on some systemic immunologic parameters and its clinical efficacy. The study involved a double-blind, placebo-controlled trial of preseasonal immunotherapy with Parietaria in 20 adults. A significant reduction of symptoms, inflammatory infiltration, and intercellular adhesion molecule-1 (ICAM-1) expression on epithelial cells after nasal challenge was evidence as long-lasting effect. No changes in serum allergen-specific IgE, IgG, and soluble eosinophil cationic protein were detected, whereas an unexpected increase of soluble ICAM-1 was found in the placebo group only. The treatment was well tolerated and a significant clinical improvement under natural allergenic exposure was observed in the active group. The present study provides, for the first time, evidence that LNIT is able to modulate the nasal allergic inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Local nasal immunotherapy has been established as an effective approach for the treatment of pollen and HDM sensitivity.1730”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1730]
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Ciprandi, G., Pronzato, C., Ricca, V, Passalacqua, G., Bagnasco, M., & Canonica, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7524984 · Cited by 117
Self-citationRak, S., H�kansson, L., & Venge, P. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80174-5 · Cited by 81
Norman, P. S., Lichtenstein, L. M., & Marsh, D. G. (1981) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(81)90200-1 · Cited by 80
Local intranasal immunotherapy for ragweed allergic rhinitis I. Clinical response
Nickelsen, J. A., Goldstein, S. E., Mueller, U. R., Wypych, J. I., Reisman, R. E., & Arbesman, C. E. (1981) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(81)90120-2 · Cited by 78
Local nasal immunotherapy for Dermatophagoides-induced rhinitis: Efficacy of a powder extract
Andri, L., Senna, G., Betteli, C., Givanni, S., Andri, G., & Falagiani, P. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90211-w · Cited by 74
Changes in nasal airways resistance on antigenic challenge in allergic rhinitis
Taylor, G., & SHIVALKAR, P. R. (1971) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1971.tb02448.x · Cited by 72
Adhesion molecules of allergic inflammation: recent insights into their functional roles
Canonica, G. W., Ciprandi, G., Buscaglia, S., Pesce, G., & Bagnasco, M. (1994) · Allergy · doi:10.1111/j.1398-9995.1994.tb00815.x · Cited by 72
Self-citationLocal nasal immunotherapy in allergic rhinitis to Parietaria: A double‐blind controlled study
Andri, L., Senna, G. E., Betteli, C., Givanni, S., Andri, G., Falagiani, P., & Lugo, G. (1992) · Allergy · doi:10.1111/j.1398-9995.1992.tb02061.x · Cited by 64
Grammer, L. C., Shaughnessy, M. A., Suszko, I. M., Shaughnessy, J. J., & Patterson, R. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90580-8 · Cited by 58
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
The Journal of Allergy and Clinical Immunology
(1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70212-5 · Cited by 1,093
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Noninjection routes for immunotherapy
Canonica, G. W., & Passalacqua, G. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.129 · Cited by 283
Self-citationPassalacqua, G., Albano, M., Fregonese, L., Riccio, A., Pronzato, C., Mela, G. S., & Canonica, G. W. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07055-4 · Cited by 260
Self-citationCanonica, G. W., Bousquet, J., Casale, T., Lockey, R. F., Baena-Cagnani, C. E., Pawankar, R., Potter, P. C., Bousquet, P. J., Cox, L. S., Durham, S. R., et al. (2009) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3181c6c379 · Cited by 251
Self-citationAllergen immunotherapy: A practice parameter second update
Cox, L., Li, J. T., Nelson, H., & Lockey, R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.019 · Cited by 240
Allergen immunotherapy: therapeutic vaccines for allergic diseases
(1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb04930.x · Cited by 234
Allergen immunotherapy: a practice parameter
Li, J. T., Lockey, R. F., Bernstein, I. L., Portnoy, J. M., & Nicklas, R. A. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63600-9 · Cited by 197
Passalacqua, G., Albano, M. F., Riccio, A., Fregonese, L., Puccinelli, P., Parmiani, S., & Canonica, G. W. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70076-x · Cited by 155
Self-citationBagnasco, M., Mariani, G., Passalacqua, G., Motta, C., Bartolomei, M., Falagiani, P., Mistrello, G., & Canonica, G. W. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70203-3 · Cited by 139
Self-citationMalling, H. ‐., Abreu‐Nogueira, J., Alvarez‐Cuesta, E., Björkstén, B., Bousquet, J. J., Caillot, D., Canonica, G. W., Passalacqua, G., Saxonis‐Papageorgiou, P., & Valovirta, E. J. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03793.x · Cited by 129
Self-citationPractice parameters for allergen immunotherapy
Nicklas, R. A., Bernstein, I. L., Blessing-Moore, J., Fìneman, S. M., GUTMAN, A., Lee, R. E., LI, J., Berger, W. E., Spector, S. L., Bernstein, I. L., et al. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80183-7 · Cited by 85
Shamji, M. H., Singh, I., Layhadi, J. A., Ito, C., Karamani, A., Kouser, L., Sharif, H., Tang, J., Handijiev, S., Parkin, R. V., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202011-4107oc · Cited by 74
Immunobiology of Asthma and Rhinitis: Pathogenic Factors and Therapeutic Options
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.ats7-99 · Cited by 62
Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects
Passalacqua, G., Albano, M., Pronzato, C., Riccio, A., Scordamaglia, A., Falagiani, P., & Canonica, G. W. (1997) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1997.tb01231.x · Cited by 47
Self-citationNasal Immunotherapy in Weed-Induced Allergic Rhinitis
Gaglani, B., Borish, L., Bartelson, B. B., Buchmeier, A. D., Keller, L., & Nelson, H. S. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63012-8 · Cited by 45
Decrease of allergen‐specific T‐cell response induced by local nasal immunotherapy
Giannarini, & Maggi, E. (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00265.x · Cited by 40
Marogna, M., Braidi, C., Bruno, M., Colombo, C., Colombo, F., Massolo, A., Palumbo, L., & Compalati, E. (2012) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2012.07.004 · Cited by 34
Marcucci, F., SENSI, L. G., Caffarelli, C., Cavagni, G., Bernardini, R., Tiri, A., Riva, G., & Novembre, E. M. (2002) · Allergy · doi:10.1046/j.0105-4538.2001.00001.x-i3 · Cited by 33
“Clinical studies have recently indicated that LNIT may reduce Inter Cellular Adhesion Molecule-1 (ICAM-1) expression on epithelial cells (20), and that both subcutaneous and local nasal immunotherapy may induce a decrease of allergen-specific T cell response (34).”
BackgroundCiprandi, G., Ricca, V., Landi, M., Passalacqua, G., Bagnasco, M., & Canonica, G. W. (1998) · International Archives of Allergy and Immunology · doi:10.1159/000023896 · Cited by 31
Self-citationPreseasonal intranasal immunotherapy in birch‐alder allergic rhinitis: A double‐blind study
Cirla, A., Sforza, N., Roffi, G. P., Alessandrini, A., Stanizzi, R., Dorigo, N., Sala, E., & Torre, F. D. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb04613.x · Cited by 31
“In any case, some clinical and also experimental observations, such as persistence of modifications in the expression of adhesion molecules by nasal endothelial cells after LNIT (30), suggest that the technique of immunotherapy here described is a real local hyposensitiza tion.”
Different methods of local allergen‐specific immunotherapy
Kägi, M. K., & Wüthrich, B. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.01153.x · Cited by 34
Specific allergen immunotherapy: time for alternatives?
Douglass, J. A., & O’Hehir, R. E. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.0022-0477.2001.01278.x · Cited by 30
Repeated allergen challenge as a new research model for studying allergic reactions
de Bruin-Weller, M. S., Weller, & de Monchy (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00434.x · Cited by 27
Immunotherapy for Inhalant Allergens
Nelson, H. S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05659-5.00095-4 · Cited by 29
Local nasal immunotherapy for allergic rhinitis: A systematic review and meta‐analysis
Kasemsuk, N., Ngaotepprutaram, P., Kanjanawasee, D., Suwanwech, T., Durham, S. R., Canonica, G. W., & Tantilipikorn, P. (2022) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23011 · Cited by 24
Self-citationLocal Nasal Specific Immunotherapy for Allergic Rhinitis
Passalacqua, G., & Canonica, G. W. (2006) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-2-3-117 · Cited by 24
Self-citationAppropriate and inappropriate use of immunotherapy
DuBuske, L. M. (2001) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62196-5 · Cited by 24
International Conference onAllergic Rhinitis in Childhood
(1999) · Allergy · doi:10.1111/j.1398-9995.1999.tb04422.x · Cited by 25
Local immunotherapy: pharmacokinetics and efficacy
Passalacqua, G., Bagnasco, M., Mariani, G., Falagiani, P., & Canonica, G. W. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb04084.x · Cited by 26
Self-citationA Multicenter Trial of Specific Local Nasal Immunotherapy
Motta, G., Passàli, D., de Vincentiis, I., Ottaviani, A., Maurizi, M., Sartoris, A., Pallestrini, E. A., Motta, S., & Salzano, F. A. (2000) · The Laryngoscope · doi:10.1097/00005537-200001000-00024 · Cited by 22
Allergen-Specific Sublingual Immunotherapy for Respiratory Allergy
Passalacqua, G., & Canonica, G. W. (2001) · BioDrugs · doi:10.2165/00063030-200115080-00003 · Cited by 19
“Similar effects on local allergic inflammation in humans were seen with intranasal administration.[25] Finally, a reduction of eosinophil cationic protein levels, which is a marker of allergic inflammation, was also described.”
BackgroundSelf-citationMolecular events in allergic inflammation: experimental models and possible modulation
Canonica, G. W., Ciprandi, G., Passalacqua, G., Pesce, G., Scordamaglia, A., & Bagnasco, M. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb04808.x · Cited by 16
Self-citationLocal nasal immunotherapy: experimental evidences and general considerations
Passalacqua, G., Albano, M., Riccio, A., Scordamaglia, A., & Canonica, G. W. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb04798.x · Cited by 15
Self-citationLocal and Systemic IgE in the Evaluation and Treatment of Allergy
Hoddeson, E. K., Pratt, E., Harvey, R. J., & Wise, S. K. (2010) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2010.02.009 · Cited by 16
Marcucci, F., SENSI, L. G., Caffarelli, C., Cavagni, G., Bernardini, R., Tiri, A., Riva, G., & Novembre, E. M. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.13149.x · Cited by 13
Therapeutic vaccines for allergic disease
Gutowska‐Owsiak, D., & Ogg, G. S. (2017) · npj Vaccines · doi:10.1038/s41541-017-0014-8 · Cited by 11
Wise, S. K., & Schlosser, R. J. (2012) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2012.06.008 · Cited by 10
Immunology of allergen immunotherapy
Rahman, R., & Wesemann, D. R. (2022) · Immunotherapy Advances · doi:10.1093/immadv/ltac022 · Cited by 10
Clinical efficacy and safety of local nasal immunotherapy
Andri, L., Senna, G., & Dama, A. R. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb04804.x · Cited by 9
Allergy to Parietaria officinalis pollen.
Cvitanović, S. (1999) · PubMed · Cited by 8
Nasal Application of Immunotherapy
Ascione, E., Lucia, A. D., Imperiali, M., Varricchio, A., & Motta, G. (2003) · KARGER eBooks · doi:10.1159/000071543 · Cited by 7
Passàli, D., Bellussi, L. M., Passàli, G. C., & Passàli, F. M. (2002) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200201500209 · Cited by 7
Preseasonal intranasal immunotherapy in birch-alder allergic rhinitis. A double-blind study
Cirla, A., Sforza, N., Roffi, G. P., Alessandrini, A., Stanizzi, R., Dorigo, N., Sala, E., & Torre, F. D. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb00089.x · Cited by 7
Sublingual immunotherapy of allergic diseases
Werner‐Klein, M., Kalkbrenner, F., & Erb, K. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.5.599 · Cited by 6
“Furthermore, local nasal immunotherapy showed no clinical efficacy after stopping the immunotherapy, suggesting the need for an annual pre-seasonal treatment [8].”
BackgroundActual therapeutic management of allergic and hyperreactive nasal disorders.
Rudack, C. (2004) · PubMed · Cited by 7
Falagiani, P. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb04752.x · Cited by 4
Nasal immunotherapy — not to be sneezed at
Haselden, & Kay (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00271.x · Cited by 4
Molecular Events in Allergic Inflammation
Ciprandi, C., Passalacqua, C., Azzarone, B. G., Bagnasco, M., & Canonica, G. W. (1998) · Elsevier eBooks · doi:10.1016/b978-012473340-4/50026-6 · Cited by 4
Self-citationImmunotherapy Update: What Delivery Techniques Are Available?
Mims, J. “. (2022) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-022-00394-6 · Cited by 3
Allergen immunotherapy: Basic concepts
Kant, S., Hassan, G., Prakash, V., Verma, A., Saheer, S., Singh, A., Singh, A., Jena, N. N., & Wani, N. (2013) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/0972-6691.116606 · Cited by 2
“[41] Several other studies have revealed encouraging results with immunotherapy using intranasal,[42] oral,[43] intralymphatic,[44] intrabronchial,[45] and epicutaneous[46] routes.”
ResultSpecific Immunotherapy in Allergic Rhinitis
Bousquet, J. J., Demoly, P. M., & Michel, F. B. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9181-3_8 · Cited by 2
POSTERS DISCUSSION SESSIONS: TUESDAY, JUNE 4, 1996
(1996) · Allergy · doi:10.1111/j.1398-9995.1999.tb04736.x · Cited by 2
(2008) · Springer eBooks · doi:10.1007/978-3-540-33395-1_13 · Cited by 1
Subcutaneous Immunotherapy for Allergic Rhinitis and Asthma
Lin, C. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-05147-1_40 · Cited by 1
Levy, J. M., & Wise, S. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54460-3.00007-5 · Cited by 1
L'immunothérapie locale Qu'en est-il à ce jour?
Passalacqua, G., & Canonica, G. W. (1998) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(98)80132-9 · Cited by 1
Self-citationPassalacqua, G., Ciprandi, G., Braido, F., D'Ulisse, S., Pasquali, M., & Canonica, G. W. (1998) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(98)80066-x · Cited by 1
Self-citationFerreira, M. B., Silva, S., Santos, M. C. P., Carlos, M., & CARLOS, A. G. P. (2001) · Clinical and Applied Immunology Reviews · doi:10.1016/s1529-1049(01)00014-9 · Cited by 1
Évaluation des nouvelles voies d'administration de la désensibilisation
Bessot, J. C., Stenger, R., Frederic de, B. L. A. Y., & Pauli, G. (2000) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(00)80046-5 · Cited by 1
Nicklas, R. A., Bernstein, J. A., Blessing-Moore, J., Fìneman, S. M., GUTMAN, A., Lee, R. E., Li, J. T., Berger, W. E., & Spector, S. L. (1996) · Cited by 1
WHO見解書 : アレルゲン免疫療法:アレルギー疾患の治療ワクチン
米国アレルギー喘息免疫学会, ヨーロッパアレルギー臨床免疫学会, ヨーロッパ小児アレルギー臨床免疫学会, Iuis, IAACIアレルゲン標準化小委員会, 日本アレルギー学会, 国立アレルギー感染病研究所, 世界保健機構, 米国アレルギー喘息免疫カレッジ, 国際喘息学会, et al. (1998) · アレルギー · doi:10.15036/arerugi.47.749 · Cited by 1
Self-citationCONTROVERSIAL FORMS OF IMMUNOTHERAPY
Terr, A. I. (2000) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(05)70171-5
Brożek, J., Bousquet, J. J., Baena-Cagnani, E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Cited by 7
Self-citationEVIDENCE-BASED MEDICINE FOR ALLERGEN-SPECIFIC IMMUNOTHERAPY
Fujieda, S., Honda, N., Yamada, M., Takabayashi, T., Ito, T., & Saitô, H. (2002) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi1982.41.1_13
Subcutaneous Immunotherapy for Allergic Rhinitis and Asthma
Lin, C. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-58726-4_40-1
Falagiani, P. (1999) · Allergy · doi:10.1111/j.1398-9995.1999.tb04752.x
Hyposensibilisierung bei Rhinitis und Asthma bronchiale
Schultze‐Werninghaus, G. (1998) · Springer eBooks · doi:10.1007/978-3-642-72021-5_30
CHAPTER 2: ALLERGEN SPECIFIC IMMUNOTHERAPY
&NA; (2009) · World Allergy Organization Journal · doi:10.1097/01.wox.0000365044.24907.e9
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01613-9
CONTROVERSIAL FORMS OF IMMUNOTHERAPY
Terr, A. I. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)00112-9
Metadata
- Authors
- Passalacqua, G., Albano, M., Ruffoni, S., Pronzato, C., Riccio, A. M., Di Berardino, L., Scordamaglia, A., & Canonica, G. W.
- Affiliations
- University of Genoa (IT)
- DIMI--Department of Internal Medicine, University of Genoa, Italy
- Venue
- American journal of respiratory and critical care medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-08-01
- Volume
- 152
- Issue
- 2
- Pages
- 461-466
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2089658906
- Cited by
- 74
- References
- 16
- Citations by year
- 2023: 1 · 2022: 3 · 2021: 1 · 2019: 1 · 2018: 3 · 2017: 1 · 2015: 1 · 2013: 1 · 2012: 2
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- Parietaria, allergic rhinitis, ICAM-1, soluble ICAM-1, nasal allergen challenge, eosinophil cationic protein, specific IgE, allergen-specific IgG, mite allergy
- MeSH terms
- Administration, Intranasal, Adult, Allergens, Blood Proteins, Desensitization, Immunologic, Double-Blind Method, Epithelium, Female, Rhinitis, Allergic, Seasonal, Humans, Immunoglobulin E, Immunoglobulin G, Immunotherapy, Male, Middle Aged, Nasal Mucosa, Nasal Provocation Tests, Placebos, Pollen, Ribonucleases, Intercellular Adhesion Molecule-1, Inflammation Mediators, Eosinophil Granule Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.